Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)-Reference-Cited by-同舟云学术

Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)

Published:2014-10 Issue:suppl_7 Volume:16 Page:vii36-vii47
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Wen Patrick Y.,Cloughesy Timothy F.,Ellingson Benjamin M.,Reardon David A.,Fine Howard A.,Abrey Lauren,Ballman Karla,Bendszuz Martin,Buckner Jan,Chang Susan M.,Prados Michael D.,Pope Whitney B.,Gregory Sorensen Alma,van den Bent Martin,Yung Wai-Kwan Alfred

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/16/suppl_7/vii36/16664696/nou226.pdf

Reference66 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States 2006–2010;Ostrom;Neuro Oncol,2013

2. The somatic genomic landscape of glioblastoma;Brennan;Cell,2013

3. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma;Sturm;Cancer Cell,2012

4. Molecular neuro-oncology in clinical practice: a new horizon;Weller;Lancet Oncol,2013

5. Malignant gliomas in adults;Wen;N Engl J Med,2008

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Neuroradiologist’s Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults;American Journal of Neuroradiology;2024-06-26

2. Metastatic glioblastoma to the lungs: a case report and literature review;CNS Oncology;2024-06-06

3. A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient;Biomarkers in Medicine;2024-05-02

4. PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction;The British Journal of Radiology;2022-01-01

5. Distinct imaging patterns of pseudoprogression in glioma patients following proton versus photon radiation therapy;Journal of Neuro-Oncology;2021-03-22